Skip to main content
. 2012 Dec 5;6(1):134–143. doi: 10.1111/eva.12033

Figure 3.

Figure 3

Windows of opportunity for different therapeutic approaches. (A) Therapy redundant with natural control; (B) Preventive therapy possible due to low malignant cell number and few or no chemoresistant clones; (C) Classic therapy following cancer detection gives a probabilistic outcome as chemoresistant clones in the malignant neoplasm are very likely; (D) Metastatic disease with low probability of curative success; low-dose palliative approaches may extend life.